{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:36:13Z","timestamp":1790739373491,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T00:00:00Z","timestamp":1711065600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023M731570"],"award-info":[{"award-number":["2023M731570"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012152","name":"National Postdoctoral Program for Innovative Talents","doi-asserted-by":"publisher","award":["BX20230151"],"award-info":[{"award-number":["BX20230151"]}],"id":[{"id":"10.13039\/501100012152","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003785","name":"Guangdong Medical Research Foundation","doi-asserted-by":"publisher","award":["A2023109"],"award-info":[{"award-number":["A2023109"]}],"id":[{"id":"10.13039\/501100003785","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304603"],"award-info":[{"award-number":["82304603"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U23A20535"],"award-info":[{"award-number":["U23A20535"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82025034"],"award-info":[{"award-number":["82025034"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFA1106700"],"award-info":[{"award-number":["2022YFA1106700"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFA1104900"],"award-info":[{"award-number":["2022YFA1104900"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","award":["KQTD20190929174023858"],"award-info":[{"award-number":["KQTD20190929174023858"]}],"id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515012859"],"award-info":[{"award-number":["2023A1515012859"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.apsb.2024.03.030","type":"journal-article","created":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T22:48:26Z","timestamp":1711406906000},"page":"2992-3008","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Fenofibrate-promoted hepatomegaly and liver regeneration are PPAR\u03b1-dependent and partially related to the YAP pathway"],"prefix":"10.1016","volume":"14","author":[{"given":"Shicheng","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guomin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1441-4840","authenticated-orcid":false,"given":"Shuaishuai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank J.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aijuan","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huichang","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2024.03.030_bib1","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/s41575-020-0314-8","article-title":"Modern therapeutic approaches for the treatment of malignant liver tumours","volume":"17","author":"Petrowsky","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2024.03.030_bib2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41575-020-0342-4","article-title":"Liver regeneration: biological and pathological mechanisms and implications","volume":"18","author":"Michalopoulos","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2024.03.030_bib3","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.cub.2012.05.016","article-title":"Hypertrophy and unconventional cell division of hepatocytes underlie liver regeneration","volume":"22","author":"Miyaoka","year":"2012","journal-title":"Curr Biol"},{"key":"10.1016\/j.apsb.2024.03.030_bib4","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1056\/NEJMra065156","article-title":"Medical progress: strategies for safer liver surgery and partial liver transplantation","volume":"356","author":"Clavien","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2024.03.030_bib5","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/SLA.0000000000002511","article-title":"ALPPS improves resectability compared with conventional two-stage hepatectomy in patients with advanced colorectal liver metastasis results from a Scandinavian multicenter randomized controlled trial (LIGRO Trial)","volume":"267","author":"Sandstrom","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.apsb.2024.03.030_bib6","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1002\/hep.20969","article-title":"Liver regeneration","volume":"43","author":"Fausto","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2024.03.030_bib7","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2353\/ajpath.2010.090675","article-title":"Liver regeneration after partial hepatectomy critical analysis of mechanistic dilemmas","volume":"176","author":"Michalopoulos","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.apsb.2024.03.030_bib8","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nrgastro.2016.97","article-title":"Liver regeneration\u2014mechanisms and models to clinical application","volume":"13","author":"Forbes","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2024.03.030_bib9","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1053\/j.gastro.2016.10.047","article-title":"Hippo signaling in the liver regulates organ size, cell fate, and carcinogenesis","volume":"152","author":"Patel","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2024.03.030_bib10","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.cub.2007.10.039","article-title":"YAP1 increases organ size and expands undifferentiated progenitor cells","volume":"17","author":"Camargo","year":"2007","journal-title":"Curr Biol"},{"key":"10.1016\/j.apsb.2024.03.030_bib11","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.53404","article-title":"YAP regulates cell size and growth dynamics via non-cell autonomous mediators","volume":"9","author":"Mugahid","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.apsb.2024.03.030_bib12","doi-asserted-by":"crossref","first-page":"46","DOI":"10.15252\/emmm.201506089","article-title":"Impaired liver regeneration in aged mice can be rescued by silencing Hippo core kinases MST1 and MST2","volume":"9","author":"Loforese","year":"2017","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.apsb.2024.03.030_bib13","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jhep.2018.05.008","article-title":"Liver regeneration requires Yap1\u2013TGF\u03b2-dependent epithelial\u2013mesenchymal transition in hepatocytes","volume":"69","author":"Oh","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2024.03.030_bib14","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaa2340","article-title":"Inhibition of the prostaglandin-degrading enzyme 15-PGDH potentiates tissue regeneration","volume":"348","author":"Zhang","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.apsb.2024.03.030_bib15","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf2304","article-title":"Pharmacological targeting of kinases MST1 and MST2 augments tissue repair and regeneration","volume":"8","author":"Fan","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.apsb.2024.03.030_bib16","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/hep.31859","article-title":"Pharmacological activation of Nrf2 enhances functional liver regeneration","volume":"74","author":"Chan","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2024.03.030_bib17","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.apsb.2020.11.021","article-title":"Constitutive androstane receptor induced-hepatomegaly and liver regeneration is partially via yes-associated protein activation","volume":"11","author":"Gao","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2024.03.030_bib18","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jhep.2016.02.040","article-title":"Constitutive androstane receptor (Car)-driven regeneration protects liver from failure following tissue loss","volume":"65","author":"Tschuor","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2024.03.030_bib19","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/hep.30131","article-title":"Pregnane X receptor regulates liver size and liver cell fate by yes-associated protein activation in mice","volume":"69","author":"Jiang","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2024.03.030_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153520","article-title":"Schisandrol B promotes liver enlargement via activation of PXR and YAP pathways in mice","volume":"84","author":"Zhao","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.apsb.2024.03.030_bib21","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.jhep.2013.07.018","article-title":"Carbamazepine promotes liver regeneration and survival in mice","volume":"59","author":"Kawaguchi","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2024.03.030_bib22","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.intimp.2017.10.030","article-title":"Dexmedetomidine promotes liver regeneration in mice after 70% partial hepatectomy by suppressing NLRP3 inflammasome not TLR4\/NF\u03baB","volume":"54","author":"Lv","year":"2018","journal-title":"Int Immunopharm"},{"key":"10.1016\/j.apsb.2024.03.030_bib23","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1124\/dmd.120.000061","article-title":"Dexamethasone-induced liver enlargement is related to PXR\/YAP activation and lipid accumulation but not hepatocyte proliferation","volume":"48","author":"Jiao","year":"2020","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.apsb.2024.03.030_bib24","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41401-021-00633-4","article-title":"PXR mediates mifepristone-induced hepatomegaly in mice","volume":"43","author":"Yao","year":"2022","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.apsb.2024.03.030_bib25","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.2165\/11208090-000000000-00000","article-title":"Fenofibrate: a review of its use in dyslipidaemia","volume":"71","author":"McKeage","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.apsb.2024.03.030_bib26","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/hep.27744","article-title":"Fibrates and cholestasis","volume":"62","author":"Ghonem","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2024.03.030_bib27","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cgh.2021.12.044","article-title":"Fenofibrate mitigates hypertriglyceridemia in nonalcoholic steatohepatitis patients treated with cilofexor\/firsocostat","volume":"21","author":"Lawitz","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2024.03.030_bib28","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s12072-015-9633-1","article-title":"Comparative clinical study between the effect of fenofibrate alone and its combination with pentoxifylline on biochemical parameters and liver stiffness in patients with non-alcoholic fatty liver disease","volume":"9","author":"El-Haggar","year":"2015","journal-title":"Hepatol Int"},{"key":"10.1016\/j.apsb.2024.03.030_bib29","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/apt.13465","article-title":"Combined ursodeoxycholic acid (UDCA) and fenofibrate in primary biliary cholangitis patients with incomplete UDCA response may improve outcomes","volume":"43","author":"Cheung","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.apsb.2024.03.030_bib30","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2036.2010.04512.x","article-title":"Pilot study: fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid","volume":"33","author":"Levy","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.apsb.2024.03.030_bib31","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.jhep.2011.12.008","article-title":"PPAR\u03b1 activation improves endothelial dysfunction and reduces fibrosis and portal pressure in cirrhotic rats","volume":"56","author":"Rodriguez-Vilarrupla","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2024.03.030_bib32","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.bbrc.2018.04.157","article-title":"FGF21 mediates the protective effect of fenofibrate against acetaminophen-induced hepatotoxicity via activating autophagy in mice","volume":"503","author":"Zhang","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.apsb.2024.03.030_bib33","doi-asserted-by":"crossref","first-page":"6321","DOI":"10.1021\/cr2001355","article-title":"PPARs and lipid ligands in inflammation and metabolism","volume":"111","author":"Harmon","year":"2011","journal-title":"Chem Rev"},{"key":"10.1016\/j.apsb.2024.03.030_bib34","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/hep.32105","article-title":"YAP\u2013TEAD mediates PPAR\u03b1-induced hepatomegaly and liver regeneration in mice","volume":"75","author":"Fan","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2024.03.030_bib35","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1139\/cjpp-2016-0140","article-title":"PPAR\u03b1-dependent increase of mouse urine output by gemfibrozil and fenofibrate","volume":"95","author":"Song","year":"2017","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.apsb.2024.03.030_bib36","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1194\/jlr.M200327-JLR200","article-title":"Fenofibrate, a ligand for PPAR\u03b1, inhibits aromatase cytochrome P450 expression in the ovary of mouse","volume":"44","author":"Toda","year":"2003","journal-title":"J Lipid Res"},{"key":"10.1016\/j.apsb.2024.03.030_bib37","doi-asserted-by":"crossref","first-page":"G283","DOI":"10.1152\/ajpgi.00205.2016","article-title":"Hepatocyte-specific PPARA expression exclusively promotes agonist-induced cell proliferation without influence from nonparenchymal cells","volume":"312","author":"Brocker","year":"2017","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.apsb.2024.03.030_bib38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41392-020-0107-0","article-title":"The role of ubiquitination in tumorigenesis and targeted drug discovery","volume":"5","author":"Deng","year":"2020","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.apsb.2024.03.030_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107990","article-title":"Macrophage K63-linked ubiquitination of YAP promotes its nuclear localization and exacerbates atherosclerosis","volume":"32","author":"Liu","year":"2020","journal-title":"Cell Rep"},{"key":"10.1016\/j.apsb.2024.03.030_bib40","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1038\/s41467-018-04620-y","article-title":"SKP2- and OTUD1-regulated non-proteolytic ubiquitination of YAP promotes YAP nuclear localization and activity","volume":"9","author":"Yao","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2024.03.030_bib41","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41575-021-00571-w","article-title":"Hippo signalling in the liver: role in development, regeneration and disease","volume":"19","author":"Russell","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2024.03.030_bib42","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/hep.30530","article-title":"Keratin 23 is a peroxisome proliferator-activated receptor alpha-dependent, MYC-amplified oncogene that promotes hepatocyte proliferation","volume":"70","author":"Kim","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2024.03.030_bib43","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jhep.2013.09.024","article-title":"Role of Myc in hepatocellular proliferation and hepatocarcinogenesis","volume":"60","author":"Qu","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2024.03.030_bib44","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1152\/ajpgi.00175.2002","article-title":"Impaired Ras membrane association and activation in PPAR\u03b1 knockout mice after partial hepatectomy","volume":"284","author":"Wheeler","year":"2003","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.apsb.2024.03.030_bib45","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1111\/bph.13928","article-title":"Inhibition of JNK signalling mediates PPAR-dependent protection against intrahepatic cholestasis by fenofibrate","volume":"174","author":"Dai","year":"2017","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.apsb.2024.03.030_bib46","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.dld.2007.10.002","article-title":"A pilot trial of fenofibrate for the treatment of non-alcoholic fatty liver disease","volume":"40","author":"Fernandez-Miranda","year":"2008","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.apsb.2024.03.030_bib47","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2165\/00003495-199040020-00007","article-title":"Fenofibrate. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in dyslipidaemia","volume":"40","author":"Balfour","year":"1990","journal-title":"Drugs"},{"key":"10.1016\/j.apsb.2024.03.030_bib48","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.jacl.2018.08.003","article-title":"Effects of free omega-3 carboxylic acids and fenofibrate on liver fat content in patients with hypertriglyceridemia and non-alcoholic fatty liver disease: a double-blind, randomized, placebo-controlled study","volume":"12","author":"Oscarsson","year":"2018","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.apsb.2024.03.030_bib49","first-page":"1082","article-title":"Effects of fibrates on the glycine conjugation of benzoic acid in rats","volume":"26","author":"Gregus","year":"1998","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.apsb.2024.03.030_bib50","doi-asserted-by":"crossref","first-page":"181","DOI":"10.4196\/kjpp.2012.16.3.181","article-title":"Reduction of food intake by fenofibrate is associated with cholecystokinin release in long-evans Tokushima rats","volume":"16","author":"Park","year":"2012","journal-title":"Korean J Physiol Pharmacol"},{"key":"10.1016\/j.apsb.2024.03.030_bib51","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/toxsci\/kfm206","article-title":"The PPAR\u03b1-humanized mouse: a model to investigate species differences in liver toxicity mediated by PPAR\u03b1","volume":"101","author":"Yang","year":"2008","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.apsb.2024.03.030_bib52","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1111\/j.1600-6143.2005.01081.x","article-title":"Small-for-size syndrome after partial liver transplantation: definition, mechanisms of disease and clinical implications","volume":"5","author":"Dahm","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.apsb.2024.03.030_bib53","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1210\/er.2018-00064","article-title":"Molecular actions of PPAR\u03b1 in lipid metabolism and inflammation","volume":"39","author":"Bougarne","year":"2018","journal-title":"Endocr Rev"},{"key":"10.1016\/j.apsb.2024.03.030_bib54","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.tox.2007.09.030","article-title":"PPAR\u03b1: mechanism of species differences and hepatocarcinogenesis of peroxisome proliferators","volume":"246","author":"Gonzalez","year":"2008","journal-title":"Toxicology"},{"key":"10.1016\/j.apsb.2024.03.030_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2021.166097","article-title":"PPARs in liver physiology","volume":"1867","author":"Berthier","year":"2021","journal-title":"Biochim Biophys Acta, Mol Basis Dis"},{"key":"10.1016\/j.apsb.2024.03.030_bib56","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.3390\/ijms21062061","article-title":"PPARs as metabolic regulators in the liver: lessons from liver-specific PPAR-null mice","volume":"21","author":"Wang","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2024.03.030_bib57","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-29455-x","article-title":"Transcriptomic analysis of hepatic cells in multicellular organotypic liver models","volume":"8","author":"Tegge","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2024.03.030_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107791","article-title":"Peroxisome proliferator-activated receptors in the pathogenesis and therapies of liver fibrosis","volume":"222","author":"Han","year":"2021","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.apsb.2024.03.030_bib59","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.3390\/cells12182273","article-title":"Effect of low testosterone levels on the expression of proliferator-activated receptor alpha in female patients with primary biliary cholangitis","volume":"12","author":"Kempinska-Podhorodecka","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.apsb.2024.03.030_bib60","article-title":"PPAR\u03b1 activation promotes liver progenitor cell-mediated liver regeneration by suppressing YAP signaling in zebrafish","volume":"13","author":"Kim","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2024.03.030_bib61","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.cell.2007.07.019","article-title":"Elucidation of a universal size-control mechanism in Drosophila and mammals","volume":"130","author":"Dong","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2024.03.030_bib62","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1073\/pnas.0911409107","article-title":"Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression","volume":"107","author":"Song","year":"2010","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.apsb.2024.03.030_bib63","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1152\/ajpgi.00077.2014","article-title":"Dynamic alterations in Hippo signaling pathway and YAP activation during liver regeneration","volume":"307","author":"Grijalva","year":"2014","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.apsb.2024.03.030_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2019.07.006","article-title":"The posttranslational modifications of Hippo\u2013YAP pathway in cancer","volume":"1864","author":"Yan","year":"2020","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"10.1016\/j.apsb.2024.03.030_bib65","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1177\/0192623310373778","article-title":"Hepatic enzyme induction: histopathology","volume":"38","author":"Maronpot","year":"2010","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.apsb.2024.03.030_bib66","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0306-3623(96)00183-8","article-title":"Zonation of cytochrome P450 expression, drug metabolism and toxicity in liver","volume":"28","author":"Lindros","year":"1997","journal-title":"Gen Pharmacol"},{"key":"10.1016\/j.apsb.2024.03.030_bib67","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/hep.1840200229","article-title":"Zonal heterogeneity of peroxisomal enzymes in rat liver: differential induction by three divergent hypolipidemic drugs","volume":"20","author":"Lindauer","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2024.03.030_bib68","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.cell.2014.03.060","article-title":"Hippo pathway activity influences liver cell fate","volume":"157","author":"Yimlamai","year":"2014","journal-title":"Cell"}],"updated-by":[{"DOI":"10.1016\/j.apsb.2025.04.016","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000}}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383524001230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383524001230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T12:16:12Z","timestamp":1762604172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383524001230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":68,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S2211383524001230"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2024.03.030","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fenofibrate-promoted hepatomegaly and liver regeneration are PPAR\u03b1-dependent and partially related to the YAP pathway","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2024.03.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}